DK0533840T3 - Behandling af kronisk nyresvigt med imidazol-angiotensin-II-receptor-antagonister - Google Patents

Behandling af kronisk nyresvigt med imidazol-angiotensin-II-receptor-antagonister

Info

Publication number
DK0533840T3
DK0533840T3 DK91912884.3T DK91912884T DK0533840T3 DK 0533840 T3 DK0533840 T3 DK 0533840T3 DK 91912884 T DK91912884 T DK 91912884T DK 0533840 T3 DK0533840 T3 DK 0533840T3
Authority
DK
Denmark
Prior art keywords
imidazole
angiotensin
renal failure
chronic renal
treatment
Prior art date
Application number
DK91912884.3T
Other languages
Danish (da)
English (en)
Inventor
David John Carini
John Jonas Vytautas Duncia
Pancras Chor-Bun Wong
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Application granted granted Critical
Publication of DK0533840T3 publication Critical patent/DK0533840T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91912884.3T 1990-06-22 1991-06-07 Behandling af kronisk nyresvigt med imidazol-angiotensin-II-receptor-antagonister DK0533840T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54235190A 1990-06-22 1990-06-22

Publications (1)

Publication Number Publication Date
DK0533840T3 true DK0533840T3 (da) 1996-12-30

Family

ID=24163446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91912884.3T DK0533840T3 (da) 1990-06-22 1991-06-07 Behandling af kronisk nyresvigt med imidazol-angiotensin-II-receptor-antagonister

Country Status (8)

Country Link
EP (1) EP0533840B1 (de)
JP (2) JPH05509086A (de)
AT (1) ATE146076T1 (de)
CA (1) CA2085584C (de)
DE (1) DE69123582T2 (de)
DK (1) DK0533840T3 (de)
GR (1) GR3022035T3 (de)
WO (1) WO1992000067A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058198A1 (en) * 1991-01-04 1992-07-05 Adalbert Wagner Azole derivatives, process for their preparation, and their use
JP3810020B2 (ja) * 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤
FR2719598B1 (fr) * 1994-05-03 1996-07-26 Rhone Poulenc Chimie Composition élastomère silicone et ses applications, notamment pour l'enduction de sac gonflable, destiné à la protection d'un occupant de véhicule.
AU677702B2 (en) * 1994-10-13 1997-05-01 Takeda Pharmaceutical Company Limited A prophylactic or therapeutic drug for renal diseases
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
DE69826854T2 (de) 1997-05-05 2006-02-02 Curis, Inc., Cambridge Therapien zur behandlung von akutem nierenversagen
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
WO2002058690A2 (en) 2001-01-26 2002-08-01 Chugai Seiyaku Kabushiki Kaisha Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
CN101596191B (zh) 2001-01-26 2011-06-15 中外制药株式会社 用作代谢调节剂的丙二酰基辅酶a脱羧酶抑制剂
AU2002241966A1 (en) 2001-01-26 2002-08-28 Chugai Seiyaku Kabushiki Kaisha Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
IL156827A0 (en) 2001-02-20 2004-02-08 Chugai Pharmaceutical Co Ltd Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
JP4773960B2 (ja) 2003-08-01 2011-09-14 中外製薬株式会社 マロニル−ＣｏＡデカルボキシラーゼ阻害剤として有用なシアノグアニジン型アゾール化合物
US7285562B2 (en) 2003-08-01 2007-10-23 Chugai Seiyaku Kabushiki Kaisha Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors
DE602004030017D1 (de) 2003-08-01 2010-12-23 Chugai Pharmaceutical Co Ltd Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer
ATE400272T1 (de) 2003-08-01 2008-07-15 Chugai Pharmaceutical Co Ltd Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer
US8257797B2 (en) 2003-11-03 2012-09-04 Bluestar Silicones France Silicone composition and process that is useful for improving the tear strength and the combing strength of an inflatable bag for protecting an occupant of a vehicle
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009134741A1 (en) * 2008-04-29 2009-11-05 Theravance, Inc. Dual-acting antihypertensive agents
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JPWO2011077712A1 (ja) * 2009-12-22 2013-05-02 興和株式会社 新規な１−（ビフェニル−４−イル−メチル）−１ｈ−イミダゾール誘導体及びこれを含有する医薬
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EP2970384A1 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonisten der guanylatcyclase und deren verwendungen
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
MX2018015247A (es) 2016-06-29 2019-08-12 Univ Montreal Heterociclos de biarilmetilo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
DE69034103T2 (de) * 1989-06-14 2004-07-15 Smithkline Beecham Corp. Imidazoalkensäure
WO1991000277A1 (en) * 1989-06-30 1991-01-10 E.I. Du Pont De Nemours And Company Substituted imidazoles
CA2032289A1 (en) * 1989-12-29 1991-06-30 Joseph A. Finkelstein Substituted 5-(alkyl) carboxamide imidazoles

Also Published As

Publication number Publication date
WO1992000067A3 (en) 1993-05-27
EP0533840B1 (de) 1996-12-11
GR3022035T3 (en) 1997-03-31
ATE146076T1 (de) 1996-12-15
JPH05509086A (ja) 1993-12-16
WO1992000067A2 (en) 1992-01-09
CA2085584A1 (en) 1991-12-23
DE69123582T2 (de) 1997-05-15
JPH11228410A (ja) 1999-08-24
DE69123582D1 (de) 1997-01-23
CA2085584C (en) 2003-02-11
EP0533840A1 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
DK0533840T3 (da) Behandling af kronisk nyresvigt med imidazol-angiotensin-II-receptor-antagonister
EP0803252A3 (de) Behandlung der Schädigung des Zentralnervensystems mit Imidazolangiotensin-II-Rezeptor-Antagonisten
NO1995004I1 (no) Losartan/ 2-butyl-4-klor-1-((2'-(1H-tetrazol-5-yl)-bifenyl-4-yl)-metyl)-5-(hydroksylmetyl)-imidazol
DE69007740D1 (de) Substituierte 5-[(Tetrazolyl)alkenyl]-Imidazole.
ATE171447T1 (de) Benzimidazole derivate
MX9204737A (es) Acidos imidazolil-alquenoicos
ES2058342T3 (es) Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii.
DK0403159T3 (da) Imidazolylalkensyrer
DE69025473D1 (de) Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
ATE371645T1 (de) Naphthalinderivate, die sich an den ep4?rezeptor binden
AR006439A1 (es) Dihidrato de eprosartano y un procedimiento para su produccion y formulacion
TR199801350T2 (xx) Yeni sikloalkil ikameli imidazoller.
KR920006323A (ko) 아자사이클릭 화합물
ATE302205T1 (de) Thieno- und furopyrimidin derivate als a2a- rezeptor antagonisten
TR200000014T2 (tr) Yeni ikameli imidazol bileşimleri.
NO972324D0 (no) Orale blandinger inneholdende Ondansetron
ATE353875T1 (de) Indolderivate
DK1175902T3 (da) Anvendelse CS-866 (olmesartan) til fremstillingen af et medikament til behandling af arteriosclerose
FI905481A0 (fi) Substituerade n-(imidazolyl) -alkylalaninderivat.
BR9104918A (pt) Utilizacao de compostos bloqueadores do receptor de angiotensina-ii,processo para o tratamento da hipertrofia e/ou hiperplasia cardial e vascular,processo para a obtencao de um preparo farmaceutico e composicao farmaceutica
TR199701536T1 (xx) Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�.
PT1019048E (pt) Uso de um antagonista do receptor da angiotensina ii para a preparacao de farmacos para aumentar a taxa de sobrevivencia de pacientes sujeitos a transplante renal
MY111445A (en) Ondansetron for rectal administration
BRPI0408979A (pt) uso de um antagonista e receptor de tipo 1 da angiotensina ii sozinho ou em combinação com uma substáncia anti-hipertensiva metabolicamente neutra, e, método para o tratamento e/ou prevenção de sìndrome metabólica